Sclerotherapy versus somatostatin in the treatment of upper digestive hemorrhage caused by rupture of esophageal varices;Escleroterapia versus somatostatina na hemorragia digestiva alta por ruptura de varizes esofágicas

Arquivos de Gastroenterologia

Volumn 37, Issue 3, 2000, Pages 148-154

  Ramires, R P ^a   Zils, C K ^a   De Mattos, A A ^a  

^a NONE   (Brazil)

Author keywords

Esophageal and gastric varices; Gastrointestinal hemorrhage; Hypertension; Liver cirrhosis; Portal; Sclerotherapy; Somotostain

Indexed keywords

SOMATOSTATIN;

ARTICLE; BLOOD TRANSFUSION; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; ESOPHAGUS RUPTURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER DYSFUNCTION; MALE; MORTALITY; SCLEROTHERAPY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0034426367     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032000000300002     Document Type: Article

References (43)

1. A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage
2. The effect of somatostatin and octreotide on intravascular oesophageal variceal pressure in patients with cirrhosis
3. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European acute bleeding oesophageal variceal episodes randomized trial
4. Approach to the management of bleeding esophageal varices: Role of somatostatin
5. Octreotide vs. sclerotherapy and octreotide for acute variceal bleeding. A pilot study
6. Portal hypertension and gastrointestinal bleeding
7. Sclerotherapy with or without octreotide for acute variceal bleeding
8. Drug therapy for variceal haemorrhage
9. Medical treatment of portal hypertension
10. Sclerotherapy alone vs. sclerotherapy plus terlipressin vs. sclerotherapy plus octreotide in the treatment of acute variceal haemorrhage
11. Randomized, double-blind, placebocontrolled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding
12. Octreotide in variceal bleeding
13. Double blind RCT of 5 day octreotide versus placebo, associated with sclerotherapy for trials failures
14. Pharmacological treatment of acute variceal bleeding
15. The treatment of portal hypertension. A metaanalytic review
16. Somatostatin and urgent sclerotherapy in active esophageal variceal bleeding
17. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis
18. Double-blind randomized controlled comparing terlipressin and somatostatin for acute variceal hemorrhage
19. Antifibrotic and hemodynamic effects of early and chronic administration of octreotide in two models of liver fibrosis in rats
20. Somatostatin vs placebo in bleeding oesophageal varices: Randomized trial and meta-analysis
21. Portal hypertension and variceal bleeding: An AASLD single topic symposium
22. Portal hypertension
23. A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage
24. Liver transplantation in the treatment of bleeding esophageal varices
25. Somatostatin versus Sengstaken balloon tamponade for primary haemostasia of bleeding esophageal varices. A randomized pilot study
26. A prospective randomised controlled clinical trial comparing sandostatin and injection sclerotherapy in the control of acute variceal haemorrhage: An interim report
27. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
28. A practical guide the management of oesophageal varices
29. Pharmacologic intervention during the acute bleeding episode
30. Portal hypertension: Diagnosis and treatment
31. Octreotide versus terlipressin in the acute variceal hemorrhage in liver cirrhosis
32. A prospective randomized trial comparing somatostatin and scleroterapy in the treatment of acute variceal bleeding
33. Transection of the oesophagus for bleeding oesophageal varices
34. A prospective randomized controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices
35. Sclerotherapy with or without somatostatin or octreotide in the treatment of acute variceal haemorrhage: Our experience
36. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
37. Prospective randomized study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation
38. A multicenter, randomized, double-blind trial of somatostatin in the management of acute hemorrhage from esophageal varices
39. Double-blind comparison of somatostatin infusion vs glipressin injection in the treatment of acute variceal haemorrhage in patients with cirrhosis
40. Randomized controled trial of sclerotherapy vs somatostatin infusion in the prevention of early rebleeding following variceal hemorrhage in patients with cirrhosis
41. Somatostatin alone or combined with emergency sclerotherapy in treatment of acute esophageal variceal bleeding: A prospective randomized trial
42. Terlipressin vs somatostatin in bleeding esophageal varices: A controlled double-blind study
43. Terlipressin (glipressin) versus somatostatin in the treatment of bleeding esophageal varices - Final report of a placebocontrolled, double-blind study